T2 Biosystems Inc. [NASDAQ: TTOO] price plunged by -2.78 percent to reach at -$0.03. The company report on June 21, 2021 that T2 Biosystems to Participate at Clinical Conferences in June and July 2021.
Company will underscore the importance of rapid diagnostic technology for detecting bloodstream infections (BSIs) and sepsis.
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced the Company’s participation in three virtual conferences this summer.
A sum of 2429906 shares traded at recent session while its average daily volume was at 4.33M shares. T2 Biosystems Inc. shares reached a high of $1.11 and dropped to a low of $1.04 until finishing in the latest session at $1.05.
Guru’s Opinion on T2 Biosystems Inc. [TTOO]:
Alliance Global Partners have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 27, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on October 08, 2020, representing the official price target for T2 Biosystems Inc. stock.
The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.07, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 6.57.
TTOO Stock Performance Analysis:
T2 Biosystems Inc. [TTOO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.67. With this latest performance, TTOO shares dropped by -25.00% in over the last four-week period, additionally sinking by -34.38% over the last 6 months – not to mention a drop of -21.05% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 36.44, with the RSI for the last a single of trading hit 32.49, and the three-weeks RSI is set at 39.28 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 1.2084, while it was recorded at 1.0760 for the last single week of trading, and 1.5139 for the last 200 days.
Insight into T2 Biosystems Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -221.72 and a Gross Margin at -13.87. T2 Biosystems Inc.’s Net Margin is presently recorded at -258.12.
Return on Total Capital for TTOO is now -102.55, given the latest momentum, and Return on Invested Capital for the company is -289.22. When it comes to the capital structure of this company, T2 Biosystems Inc. [TTOO] has a Total Debt to Total Equity ratio set at 652.29. Additionally, TTOO Total Debt to Total Capital is recorded at 86.71, with Total Debt to Total Assets ending up at 71.98. Long-Term Debt to Equity for the company is recorded at 639.10, with the Long-Term Debt to Total Capital now at 84.95.
Reflecting on the efficiency of the workforce at the company, T2 Biosystems Inc. [TTOO] managed to generate an average of -$316,203 per employee. Receivables Turnover for the company is 4.58 with a Total Asset Turnover recorded at a value of 0.34.T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.90 and a Current Ratio set at 4.30.
T2 Biosystems Inc. [TTOO] Insider Position Details
There are presently around $28 million, or 17.70% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 6,517,731, which is approximately 5.37% of the company’s market cap and around 0.70% of the total institutional ownership; GOLDMAN SACHS GROUP INC, holding 4,358,817 shares of the stock with an approximate value of $4.58 million in TTOO stocks shares; and BLACKROCK INC., currently with $3.16 million in TTOO stock with ownership of nearly 36.336% of the company’s market capitalization.
Positions in T2 Biosystems Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 53 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 7,136,679 shares. Additionally, 29 investors decreased positions by around 2,084,691 shares, while 14 investors held positions by with 17,267,127 shares. The mentioned changes placed institutional holdings at 26,488,497 shares, according to the latest SEC report filing. TTOO stock had 29 new institutional investments in for a total of 2,123,686 shares, while 10 institutional investors sold positions of 459,173 shares during the same period.